The contractor shall provide automated immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining platform/S, antibody stains, reagents, and supplies used to support the anatomic…

Active Indefinite Delivery Contract Awarded Last action

Contract number
W81K0225DA013
Awardee
Awarding agency
Task orders
2 $342,049 obligated

Award facts

Combined order value
$574,774 Current and potential, with all options
Last date to order 22% complete
IDV ceiling 23% used
$1,500,000.00
Maximum order
$245,765.81
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded an indefinite-delivery contract to Roche Diagnostics Corporation for $1.5 million on October 1, 2025, as a single award with no set-aside. The contract covers automated immunohistochemistry and in-situ hybridization slide staining platforms, antibody stains, reagents, and supplies to support the anatomic pathology mission at Madigan Army Medical Center. Performance runs through September 30, 2030.

Place of performance is Madigan Army Medical Center, with a delivery order issued under this IDIQ already performing at Joint Base Lewis-McChord, Washington. The originating requirement calls for IHC-ISH platform systems and associated consumables to enable pathologists and clinicians to determine disease status of biopsy tissues for proper diagnosis.

On October 1, 2025, the Defense Health Agency issued a delivery order under this IDIQ to Roche Diagnostics for an automated immunohistochemistry and in-situ hybridization platform at Joint Base Lewis-McChord, Washington, with a ceiling of $342,049.17 and completion by September 30, 2027, on a firm fixed-price basis.

Description

The contractor shall provide automated immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining platform/S, antibody stains, reagents, and supplies used to support the anatomic pathology mission at madigan army medical center.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00002 · Immunohistochemistry and in-situ hybridization platform $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract W81K0225DA013?

W81K0225DA013 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on October 1, 2025.

How much is contract W81K0225DA013 worth?

Orders under W81K0225DA013 have obligated $342,049. Their combined current value, with exercised options, is $574,774. W81K0225DA013's own ceiling is $1,500,000. A single order can be worth up to $245,766.

How many orders have been placed under contract W81K0225DA013?

2 orders have been placed under W81K0225DA013, the latest on October 1, 2026.

Who can order from contract W81K0225DA013?

W81K0225DA013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0225DA013 competed?

The extent of competition for W81K0225DA013 was competed under sap. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV